Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

The compound was successfully made and shows potential for treating prostate cancer.

Oral zinc gluconate and topical steroids significantly improved a rare scalp condition in three elderly patients.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

The research provided a detailed view of the non-keratinous parts of human hair fibers.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Bimatoprost is slightly more effective than minoxidil for eyebrow growth, and both are safe.

1α,25-dihydroxyvitamin D3 directly affects cartilage growth and development.

Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.

Glioblastoma cells can make androgens, which might help the tumor grow.

Microscopic hair features can identify different Cauda Cervi species.

Using more minoxidil solution can lead to better hair growth, but people often use only half the recommended amount. Education and motivation can improve results.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The patient recovered well and returned to college without any lasting issues.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Low-dose oral minoxidil for hair loss seems to have rare side effects, but more research is needed to confirm its safety.

A new compound that could treat various androgen-related conditions was created and analyzed.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

CaBP1 and CaBP2 are important for maintaining hearing by supporting continuous calcium currents and nerve signaling in the ear.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.